样式: 排序: IF: - GO 导出 标记为已读
-
Post orgasmic illness syndrome: a review Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-14 Benjamin Olasunkanmi Odusanya, Ian Pearce, Vaibhav Modgil
-
The impact of digital media on sexuality: a descriptive and qualitative study Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-14 Ana Filipa Beato, Patrícia M. Pascoal, Joana Rodrigues
-
The role and needs of family doctors in sexual medicine: contributions of a preliminary Portuguese qualitative study for a global action Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-13 Margarida G. Rodrigues, Andreia A. Manão, Nuno Tomada, Patrícia M. Pascoal
Sexual health is fundamental for overall well-being and quality of life, making it the focus of intervention in Sexual Medicine (SM). Within the National Health Services, Primary Care Physicians (PCPs) guarantee comprehensive care in a biopsychosocial action, including in sexual health. This exploratory study aimed to investigate PCPs’ perceptions about their role in SM and how to improve it. A cross-sectional
-
Ghattas modification of inflatable penile prosthesis: a proposed surgical technique for efficient penile prosthesis implantation Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-13 Osama Ghattas, Moustafa Gaber Menshawy
-
First worldwide correction of ventral Peyronie’s disease utilizing rigicon inflatable penile prosthesis combined with plaque incision & grafting with collagen fleece (PICS-technique) for residual curvature Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-13 Georgios Hatzichristodoulou, Mehmet Hamza Gültekin, Hamdi Özkara, Emre Akkus
-
Comment on: Assessing ChatGPT’s ability to answer questions pertaining to erectile dysfunction Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-11 Jacob S. Hershenhouse, Giovanni E. Cacciamani
-
Himplant® subcutaneous penile implant improves penile appearance and erectile dysfunction after radical prostatectomy: a case series Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-05 Robert J. Valenzuela, James J. Elist, Daniel Moon, Luka Cvijanovic, Steven K. Wilson
-
Ursodeoxycholic acid ameliorates erectile dysfunction and corporal fibrosis in diabetic rats by inhibiting the TGF-β1/Smad2 pathway Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-07 Irem Cavusoglu Nalbantoglu, Serhat Sevgi, Gokcen Kerimoglu, Mine Kadıoglu Duman, Nuri Ihsan Kalyoncu
-
Evaluating the management trends for priapism and assessing the risk of priapism after in-office intracavernosal injections: a cross-sectional analysis Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-06 Joon Yau Leong, Zachary J. Prebay, David Ebbott, Michael Li, Paul H. Chung
We describe the management trends of patients suffering from any priapism and evaluate the risks of developing priapism after intracavernosal injections (ICI) performed in office. We queried TriNetX for two separate male adult cohorts - those presenting with any priapism based on International Classification of Disease code, N48.3 (priapism) and those who underwent ICI in office based on Current Procedural
-
The online sexual disinhibition effect Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-06 Ryan Varghese
Coined by Suler [1], the online disinhibition effect (ODE) elucidates the attenuation of psychological barriers in individuals, during online interactions, thereby eliciting behaviors that diverge from those exhibited during face-to-face interactions [1]. The online milieu confers anonymity, is characterized by facile communication, and lacks eye contact, thereby serving as a crucible for the manifestation
-
Adipose-derived stem cells: an upcoming novel therapeutic in the management of Erectile dysfunction post radical prostatectomy in prostate cancer patients Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-05 Gargi Digholkar, Ryan Varghese, Kavita Pal, Rohit Sharma
Globally, prostate cancer (PC) is one of the most prevalent cancers and ranks as the fourth most diagnosed cancer in men. In 2020 alone, over 1.4 million individuals were diagnosed with PC. Contrary to popular perceptions associating PC with men aged 65 years or older, recent statistics underscore that over 10% of recent diagnoses in the United States are in men aged <55 years [1]. Although most men
-
Unveiling the molecular Hallmarks of Peyronie’s disease: a comprehensive narrative review Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-07 Ali Şahin, Huseyn Babayev, Lorenzo Cirigliano, Mirko Preto, Marco Falcone, Emre Altıntas, Murat Gül
-
Glans hypermobility scale (GHS): A simple grading scale and description of a modified glanspexy technique Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-05 Tobias Köhler, Abrar Mian, Matthew Ziegelmann, Nicole Dodge, Raza Mian, Sevann Helo, Alfredo Suarez-Sarmiento, Matthew Brennan, Paul Perito
-
Using social media for male sexual health: what do we miss? A perspective article on good practices and missing evidence Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-05 Filippo Maria Nimbi, Livio Ricciardi, Roberta Galizia, Vittorio Lingiardi
Social media are popular and play a key role in influencing, informing, and stimulating users in their everyday lives. People (especially adolescents and young adults) increasingly use social media to get and share sexual health-related information. Studies have shown encouraging results on using social media for sexual health communication improving attitudes and behaviors, although the current quality
-
The association between serum 25-hydroxyvitamin D levels and erectile dysfunction: a two-sample Mendelian randomization analysis Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-03-01 Dawei Gao, Cheng Chen, Ziliang Wu, Huakang Li, Cheng Xie, Bo Tang
-
Sub-gluteal ligation of the internal pudendal vein for management of veno-occlusive erectile dysfunction (Shaeer’s Vein Ligation–I): the cadaveric study Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-29 Osama Shaeer, Ehab A. A. El-Shaarawy, Hossam Y. Emam, Islam Elsisi, Eslam Sokar, Kamal Shaeer
-
A phase 2 randomized, placebo-controlled crossover trial to evaluate safety and efficacy of platelet-rich plasma injections for Peyronie’s disease: clinical trial update Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-29 Braian R. Ledesma, David A. Velasquez, Christabel Egemba, Manuel Molina, Emad Ibrahim, Francesco Costantini-Mesquita, Nicholas A. Deebel, Sunwoo Han, Isildinha M. Reis, Russell Saltzman, Ranjith Ramasamy
-
Long-term outcomes of penile squamous cell carcinoma in men age ≤50 years old compared with men >50 years old from a single tertiary referral centre: a propensity score matched analysis Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-29 Karl H. Pang, Giuseppe Fallara, Morwarid Hemat, Akash Ghosh, Aiman Haider, Alex Freeman, Paul Hadway, Raj Nigam, Rowland Rees, Anita Mitra, Constantine Alifrangis, Asif Muneer, Hussain M. Alnajjar
-
Hard flaccid syndrome symptoms, comorbidities, and self-reported efficacy and satisfaction of treatments: a cross-sectional survey Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-28 Jenny Niedenfuehr, David M. Stevens
-
ManAgement of pRiapiSm and its impact on outcomes: an international register (MARS study) – the first international, multicenter, observational study regarding priapism in perspective Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-28 Maria Giovanna Asmundo, Giorgio Ivan Russo
-
The impact of premature ovarian insufficiency on sexual function; which domain is mostly disrupted? Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-28 Maryam Farahmand, Fahimeh Ramezani Tehrani
-
The canary in the coal mine. Comment on “Association between cardiometabolic index and erectile dysfunction among US adults: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2001–2004” Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-24 Dimitri Yannas, Andrea Sansone, Emmanuele A. Jannini
The relation between erectile dysfunction (ED) and cardiovascular disease (CVD) is profound and bidirectional. On the one hand, ED shares many risk factors with cardiovascular (CV) and metabolic diseases, and on the other hand, ED itself is considered a risk factor for the development of major adverse cardiovascular events [1]. The new and interesting study by Zhang and colleagues adds another piece
-
Global prevalence of erectile dysfunction and its associated risk factors among men with type 1 diabetes: a systematic review and meta-analysis Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-23 Xiaolong Zhang, Zhirong Zhu, Guiliang Tang
-
Plication surgery does not produce additional loss of length in Peyronie’s disease patients Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-22 Giulio Garaffa, Fabio Traunero, Francesco Claps, Nicola Pavan, Giulio Rossin, Andrea Piasentin, Michele Rizzo, Arianna Biasatti, Federico Zorzi, Carlo Trombetta, Giovanni Liguori, Luca Ongaro
Nesbit’s procedure remains a cornerstone in surgical management of Peyronie’s disease, despite the subjective loss of penile length. This retrospective study demonstrates that the perceived length loss has already occurred prior to surgery and that the Nesbit’s procedure does not produce additional loss of length. Ninety-one patients who had undergone Nesbit’s procedure between 2017 and 2022 at the
-
Uncovering the interhospital price variations for vasectomies in the United States Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-22 Sherry Mortach, Nicholas Sellke, Stephen Rhodes, Helen H. Sun, Kimberly Tay, Ramy Abou Ghayda, Aram Loeb, Nannan Thirumavalavan
-
Use of Himplant® for correction of residual deformity following prior treatment of peyronie’s disease: a case series Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-23 Laurence A. Levine, Elsayed Desouky, James J. Elist, Daniel Moon, Steven K. Wilson
-
Comment on “Patients’ perspectives on informational needs surrounding gender affirming vaginoplasty” Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-22 Marco Falcone, Lorenzo Cirigliano
We read with interest the article by Millman et al. [1] dedicated to AMAB (Assigned Male At Birth) individuals underwent genital gender affirming surgery (GGAS) whose informational needs were investigated through an anonymous survey. The demand for GGAS has steadily increased throughout the years worldwide [2]. On these regards, authors reported a threefold increase in gender-affirming vaginoplasty
-
Comment on: Platelet-rich plasma intracavernosal injections for the treatment of primary organic erectile dysfunction: a systematic review and meta-analysis of contemporary controlled studies Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-21 David Romeiro Victor, Bárbara Vieira Lima Aguiar Melão
We congratulate the authors for their exemplary work in conducting a comprehensive systematic review and meta-analysis regarding the application of intracavernous platelet-rich plasma (PRP) injections in the treatment of erectile dysfunction (ED) [1]. They demonstrated exceptional proficiency through their summarization and insightful discussion of the existing evidence regarding a relatively new therapy
-
A brief unstructured literature review on the history of paraphilias Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-13 Safiye Tozdan
This unstructured review is based on a comprehensive literature search leading to a variety of selected studies that summarize the historical development of paraphilias. Firstly, paraphilias in ancient times are discussed. Secondly, the development of paraphilia diagnoses, including current critical aspects, is outlined. Finally, a short description of the development of treatment approaches for individuals
-
Advancements and challenges in Peyronie’s disease: a personal journey and current perspectives Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-08 Laurence A. Levine
-
No difference between split-thickness and full-thickness skin grafts for surgical repair in adult acquired buried penis regarding surgical and functional outcomes: a comparative retrospective analysis Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-07 Murat Gül, Natalia Plamadeala, Marco Falcone, Mirko Preto, Lorenzo Cirigliano, Federica Peretti, Ilaria Ferro, Martina Scavone, Paolo Gontero
-
Commentary on “Attention-deficit hyperactivity disorder medication use is associated with testosterone hypofunction” Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-06 Onuralp Ergun, Ahmet Gudeloglu
“Attention-Deficit Hyperactivity Disorder Medication Use is Associated with Testosterone Hypofunction – Results from a National Claims Database Analysis” by Ostdiek-Wille et al. [1], investigates a possible link between chronic Attention-Deficit Hyperactivity Disorder (ADHD) stimulant medication use and the associated risk of developing testosterone hypofunction in adult males. The authors used a large-scale
-
Response to the Commentary on: Intracavernosal pressure of the erect penis in children with hypospadias Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-03 Michael Frumer, David Ben-Meir
We would like to thank Dr. Ibis et al. for their comments [1]. Our study presents new objective data regarding penile erection in children with hypospadias. Intracavernosal pressures (ICP) were assessed during the routine artificial erection test conducted at the beginning of hypospadias surgery. The measurements included children with varying degrees of hypospadias severity, both with and without
-
Effect of bulbospongiosus muscle injection with botulinum-A toxin for treatment of lifelong premature ejaculation; a randomized controlled trial Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-02-02 Khaled Almekaty, Ahmed Ghaith, Maged Ragab, Ayman Rashed, Ayman Hagras, Ayman Ghoneem, Amr Abdel Raheem, Mohamed H. Zahran
-
The percentage of men counseled by urologists who received a vasectomy mildly increased after the publication of the AUA vasectomy guideline Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-30 Max J. Hyman, Zhong Huang, Omer A. Raheem
-
Commentary on: The prevalence and risk factors of sexual dysfunction among females with inflammatory bowel disease: a systematic review and meta-analysis Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-27 Ilaha Isali, Ali Furkan Batur
The prevalence and risk factors of sexual dysfunction in females with inflammatory bowel disease (IBD) have gained attention in recent years, prompting extensive epidemiological research. This commentary offers a critical analysis of a systematic review and meta-analysis titled “The prevalence and risk factors of sexual dysfunction among females with inflammatory bowel disease: a systematic review
-
Preoperative counseling for penile implant surgery: standardized approach in a high-volume center of excellence Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-26 Andries Van Huele, Mariet Lenaers, Koenraad Van Renterghem
-
Causal effects of gut microbiota on the risk of erectile dysfunction: a Mendelian randomization study Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-25 Ran Xu, Shuo Liu, Lu-Yi Li, Ying Zhang, Bo-Qin Fang, Guang-Cheng Luo, Xin-Jun Wang
-
Sleep-related painful erections: a survey-based analysis of patient-reported experiences with diagnosis and management Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-23 Rachel Wong, Dhiraj S. Bal, David Chung, Faysal Yafi, Supanut Lumbiganon, Premal Patel
-
Prevalence of sexual dysfunction and pursuit of sexual medicine evaluation among male physicians—a survey Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-20 Jasmine S. Lin, Justin M. Dubin, Jonathan Aguiar, Daniel R. Greenberg, Nelson E. Bennett, Robert E. Brannigan, Joshua A. Halpern
-
Response to commentary on: assessing ChatGPT’s ability to answer questions pertaining to erectile dysfunction: can our patients trust it? Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-19 Shirin Razdan, Robert J. Valenzuela
In our manuscript titled “Assessing ChatGPT’s Ability to Answer Questions Pertaining to Erectile Dysfunction: Can Our Patients Trust It?” we extensively queried ChatGPT’s ability to accurately and comprehensively respond to common patient erectile dysfunction (ED) questions [1]. Our results showed mixed accuracy, with reading levels far more advanced than what is recommended for the average patient
-
Efficacy of top flat magnetic stimulation for chronic pelvic pain in men: preliminary results Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-18 Nicola Mondaini, Mauro Gacci, Tommaso Cai, Francesco Lotti, Vincenzo Li Marzi, Fabio Crocerossa, Andrea Abramo, Francesco Cantiello, Irene Fusco, Alessandra Comito, Sara Tanguenza, Rocco Damiano
-
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie’s Disease: A retrospective cohort study Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-16 Emil Durukan, Rune Kraglund, Shad Azad Rashid, Tine Thorkilgaard, Christian Fuglesang Skjødt Jensen, Mikkel Fode
Treatment with Phosphodiesterase Type 5 inhibitors (PDE5is) has shown promise in managing Peyronie’s disease (PD) during its active phase. In a retrospective cohort study of 133 PD patients, we compared daily PDE5i treatment (sildenafil 25 mg or tadalafil 5 mg) in Group 1 (n = 101) to no treatment in Group 2 (n = 32). The mean age ± SD was 58.5 ± 10, (range: 29-77) years in Group 1 and 59 ± 13.7 years
-
Comment on: “Current opinions on the management of prolonged ischaemic priapism: does penoscrotal decompression outperform corporoglanular tunneling?” Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-17 Wai Gin Lee, Andrea Gobbo, David Ralph
There is broad consensus that ischaemic priapism requires prompt emergent treatment. Delays in decompression will result in erectile dysfunction (ED) with the associated risks of penile shortening and fibrosis. Erectile function is closely associated with the duration of ischaemia [1]. Bennett and Mulhall showed that if ischaemic priapism is reversed within 12 h from onset, 100% of patients recover
-
Transdermal application of H100 gel to the penile shaft in patients with Peyronie’s disease infiltrates the tunica albuginea Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-13 Jeffry Twidwell, Joseph Mahon, Dean Tortorelis, Laurence Levine
Treatment options for Peyronie’s disease (PD) remain limited. Topical H100 gel, (Hybrid Medical, Edina, USA), which contains nicardipine, super oxide dismutase and emu oil showed safety and efficacy in a previous small double-blind placebo-controlled pilot study. The present study evaluates if topically applied H100 gel applied to the penile shaft infiltrates the tunica albuginea. Nicardipine is a
-
Pornography and sexual function in the post-pandemic period: a narrative review from psychological, psychiatric, and sexological perspectives Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-06 Kathryn Fotinos, Andrea Sansone, Alexandria Greifenberger, Martin A. Katzman, Tommaso B. Jannini, Yacov Reisman, Erika Limoncin, Emmanuele A. Jannini
-
Untreated hypogonadism and testosterone replacement therapy in hypogonadal men are associated with a decreased risk of subsequent prostate cancer: a population-based study Int. J. Impot. Res. (IF 2.6) Pub Date : 2024-01-05 Kian Asanad, Joshua J. Horns, Nathan Driggs, Mary K. Samplaski, James M. Hotaling
We sought to understand the relationship between hypogonadism and testosterone replacement therapy (TRT) in hypogonadal men on the risk of developing localized and metastatic prostate cancer. We used the Merative MarketScan database of commercial claims encounters to identify men diagnosed with hypogonadism. These men were matched to eugonadal men who served as controls. Multivariate negative binomial
-
Evaluating treatment pathways for Peyronie’s disease utilizing the TriNetX research registry Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-30 Anushka Ghosh, Joon Yau Leong, Halle Foss, David Ebbott, Zachary Prebay, Michael Li, Paul H. Chung
-
Paraphilic disorders, psychopathy, and those who sexually offend: a narrative review of treatment modalities Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-30 J. Nicholas Shumate, Seo Ho Song, Fabian M. Saleh
-
Comment on: Intracavernosal pressure of the erect penis in children with hypospadias Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-27 Muhammed Arif İbiş, Onder Yaman, Tarkan Soygur
We perused with interest the research study titled “Intracavernosal Pressure of the erect penis in children with hypospadias”, authored by Ben-Meir and colleagues and published in the International Journal of Impotence Research [1]. The study addresses an important aspect of hypospadias surgery by investigating intracavernosal pressure (ICP) and the relationship of ICP to prior corporotomies. The authors
-
Fixed drug eruption-induced balanoposthitis: a case report Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-25 Jingyi Zhang, Fang Yang, Meijing Wang, Aili Yang, Feng Zhang, Yao Xiao, Yanxin Guan, Xujun Yu
-
Comprehensive analysis of biological landscape of oxidative stress-related genes in diabetic erectile dysfunction Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-25 Qingjun Meng, Yinwei Chen, Lingang Cui, Yinsheng Wei, Teng Li, Penghui Yuan
-
A rare cause of anejaculation: mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome: case report Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-21 Selman Unal
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome is an extremely rare multisystem disorder with autosomal recessive inheritance and impairs mitochondrial DNA replication, which causes myopathy and neurodegeneration. The classical symptoms of this syndrome are progressive gastrointestinal dysmotility and peripheral neuropathy. We are presenting a patient who had MNGIE syndrome
-
Attention-deficit hyperactivity disorder medication use is associated with testosterone hypofunction–results from a national claims database analysis Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-21 Garett P. Ostdiek-Wille, Kyle C. Bavitz, Taylor P. Kohn, Christopher M. Deibert
-
The role of metaverse on sexual health of people with disabilities: narrative review Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-21 Erika Limoncin, Benedetta Gaudio, Andrea Sansone, Tommaso B. Jannini, Giacomo Ciocca, Daniele Mollaioli, Emmanuele A. Jannini
-
Association between cardiometabolic index and erectile dysfunction among US adults: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2001-2004 Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-20 Yuyang Zhang, Xu Wu, Guodong Liu, Xingliang Feng, Wei Zhang, Hui Jiang, Xiansheng Zhang
-
Current opinions on the management of prolonged ischemic priapism: does penoscrotal decompression outperform corporoglanular tunneling? Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-19 Maia E. VanDyke, Wesley J. Smith, Levi C. Holland, Brian T. Langford, Eshan G. Joshi, Benjamin M. Dropkin, Benjamin N. Breyer, Faysal A. Yafi, Niels V. Johnsen, David W. Barham, Gregory A. Joice, Mikkel Fode, Bryce P. Franzen, Steven J. Hudak, Allen F. Morey
-
Commentary on “Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie’s disease: a retrospective cohort study” Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-18 Celeste Manfredi, Eugenio Bologna, Leslie Claire Licari
In an article recently published in the International Journal of Impotence Research, Durukan et al. evaluated the impact on penile curvature and pain duration of Phosphodiesterase Type 5 Inhibitors (PDE5Is) administrated in the acute phase of Peyronie’s disease (PD) [1]. A total of 133 patients with acute PD were included in this single-center retrospective study. Group 1 (n = 101) received PDE5Is
-
Rare, but potentially risky, high individual increase of self-reported sexual arousal in men, who have committed sexual offenses against children, while being confronted with experimental sexual stimuli — a retrospective data analysis Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-12 Kirsten Jordan, Peter Fromberger, Isabel Müller, Tamara Sheila Nadine Wild, Jürgen Leo Müller
-
Commentary on: Safety and feasibility of percutaneous needle tunneling with platelet-rich plasma injections for Peyronie’s disease in the outpatient setting: a pilot study Int. J. Impot. Res. (IF 2.6) Pub Date : 2023-12-08 Ali Şahin, Murat Gül
In the article titled ‘Safety and Feasibility of Percutaneous Needle Tunneling with Platelet-Rich Plasma Injections for Peyronie’s Disease in the Outpatient Setting: A Pilot Study,’ Zugail et al. [1] presented data from a non-randomized, prospective pilot study that investigated the antifibrotic effects of platelet-rich plasma (PRP) injection combined with percutaneous needle tunneling (PNT) and followed